SBIO Holdings Information

SBIO is an equity ETF with a total of 89 individual holdings. The top holdings are Kymera Therapeutics stock at 4.22%, CG Oncology at 3.65%, Mirum Pharmaceuticals at 3.55%, Celcuity at 3.26%, and Alkermes at 3.11%.

Total Holdings

Top 10 Percentage

31.23%

Asset Class

Equity

ETF Category

Health

Assets

132.44M

PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	KYMR	Kymera Therapeutics, Inc.	4.22%	70,405
2	CGON	CG Oncology, Inc.	3.65%	72,817
3	MIRM	Mirum Pharmaceuticals, Inc.	3.55%	52,044
4	CELC	Celcuity Inc.	3.26%	39,901
5	ALKS	Alkermes plc	3.11%	143,718
6	XENE	Xenon Pharmaceuticals Inc.	3.03%	71,743
7	FOLD	Amicus Therapeutics, Inc.	3.01%	270,798
8	VKTX	Viking Therapeutics, Inc.	2.48%	99,656
9	CRNX	Crinetics Pharmaceuticals, Inc.	2.47%	90,296
10	APGE	Apogee Therapeutics, Inc.	2.45%	48,292
11	ACAD	ACADIA Pharmaceuticals Inc.	2.35%	147,039
12	DNTH	Dianthus Therapeutics, Inc.	2.30%	38,354
13	GPCR	Structure Therapeutics Inc.	2.28%	61,093
14	NAMS	NewAmsterdam Pharma Company N.V.	2.21%	99,153
15	SYRE	Spyre Therapeutics, Inc.	2.15%	67,737
16	DNLI	Denali Therapeutics Inc.	2.12%	136,773
17	EWTX	Edgewise Therapeutics, Inc.	2.07%	92,510
18	VERA	Vera Therapeutics, Inc.	1.92%	61,537
19	IDYA	IDEAYA Biosciences, Inc.	1.91%	75,735
20	TARS	Tarsus Pharmaceuticals, Inc.	1.82%	36,705
21	TVTX	Travere Therapeutics, Inc.	1.64%	79,554
22	MAZE	Maze Therapeutics, Inc.	1.53%	41,499
23	IRON	Disc Medicine, Inc.	1.47%	32,906
24	DAWN	Day One Biopharmaceuticals, Inc.	1.47%	89,084
25	APLS	Apellis Pharmaceuticals, Inc.	1.46%	110,238

Showing 25 of 89 holdings

Subscribe to see the full list

Activate Now

As of Mar 20, 2026